Potential for cell-transplant therapy with human neuronal precursors to treat neuropathic pain in models of PNS and CNS injury: Comparison of hNT2.17 and hNT2.19 cell lines

Pain Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Eaton, Mary J ^a   Berrocal, Yerko ^b   Wolfe, Stacey Q ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873823204     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2012/356412     Document Type: Article

References (207)

1. MacPherson R. D., New directions in pain management. Drugs of Today 2002 38 2 135 145 2-s2.0-0036488657 10.1358/dot.2002.38.2.668325 (Pubitemid 34266583)
2. Dworkin R. H., An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clinical Pain 2002 18 6 343 349 2-s2.0-0036843815 10.1097/00002508-200211000-00001 (Pubitemid 35291574)
3. Turk D. C., Okifuji A., Treatment of chronic pain patients: clinical outcomes, cost-effectiveness, and cost-benefits. Critical Reviews in Physical and Rehabilitation Medicine 1998 10 2 181 208 2-s2.0-0031759034 (Pubitemid 28495830)
4. Breivik H., Opioids in cancer and chronic non-cancer pain therapy: indications and controversies. Acta Anaesthesiologica Scandinavica 2001 45 9 1059 1066 2-s2.0-0034781603 10.1034/j.1399-6576.2001.450902.x (Pubitemid 32996071)
5. Woolf C. J., Mannion R. J., Neuropathic pain: aetiology, symptoms, mechanisms, and management. The Lancet 1999 353 9168 1959 1964 2-s2.0-0033526651 10.1016/S0140-6736(99)01307-0 (Pubitemid 29255720)
6. Siddall P. J., Yezierski R. P., Loeser J., Pain following spinal cord injury: clinical features, prevalence, and taxonomy. IASP Newsletter 2000 3 3 7
7. Jain K. K., Cell therapy for pain. Expert Opinion on Biological Therapy 2008 8 12 1847 1853
8. Jeon Y., Cell based therapy for the management of chronic pain. Korean Journal of Anesthesiology 2011 60 1 3 7
9. Klass M., Gavrikov V., Drury D., Stewart B., Hunter S., Denson D. D., Hord A., Csete M., Intravenous mononuclear marrow cells reverse neuropathic pain from experimental mononeuropathy. Anesthesia and Analgesia 2007 104 4 944 948 2-s2.0-34047254693 10.1213/01.ane.0000258021.03211.d0 (Pubitemid 46548326)
10. Eaton M. J., Wolfe S. Q., Widerstrom-Noga E., Use of progenitor cells in pain management. Stem Cell & Regenerative Medicine 2010 Oak Park, Ill, USA Bentham Science 94 128
11. Eaton M. J., Sagen J., Sanberg P. R., Davis C. D., Cell therapy for models of pain and traumatic brain injury. Cell Therapy for Brain Repair 2007 Totowa, NJ, USA The Humana Press 199 239
12. Eaton M., Common animal models for spasticity and pain. Journal of Rehabilitation Research and Development 2003 40 4 41 54 2-s2.0-0043234144 (Pubitemid 36988679)
13. Eaton M. J., Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies. Journal of the Peripheral Nervous System 2000 5 2 59 74 2-s2.0-0033921755 10.1046/j.1529-8027.2000.00006.x (Pubitemid 30451708)
14. Lazorthes Y., Sallerin B., Verdie J. C., Sol J. C., Duplan H., Tkaczuk J., Tafani M., Bastide R., Bes J. C., Management of intractable cancer pain: from intrathecal morphine to chromaffin cell allograft. Neurochirurgie 2000 46 5 454 465 2-s2.0-0033710497
15. Wilson S. P., Yeomans D. C., Genetic therapy for pain management. Current Review of Pain 2000 4 6 445 450 2-s2.0-0033647681
16. Eaton M. J., Herman J. P., Jullien N., Lopez T. L., Martinez M., Huang J., Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination for use in cell therapy for pain after partial nerve injury. Experimental Neurology 2002 175 1 49 60 2-s2.0-0036255266 10.1006/exnr.2002.7883 (Pubitemid 34507909)
17. Hottinger A. F., Aebischer P., Treatment of diseases of the central nervous system using encapsulated cells. Advances and Technical Standards in Neurosurgery 1999 25 3 20 2-s2.0-0032603096
18. Widerström-Noga E. G., Felipe-Cuervo E., Broton J. G., Duncan R. C., Yezierski R. P., Perceived difficulty in dealing with consequences of spinal cord injury. Archives of Physical Medicine and Rehabilitation 1999 80 5 580 586 2-s2.0-0032896945 10.1016/S0003-9993(99)90203-4 (Pubitemid 29221051)
19. Siddall P. J., Management of neuropathic pain following spinal cord injury: now and in the future. Spinal Cord 2009 47 5 352 359 2-s2.0-67349282684 10.1038/sc.2008.136
20. Siddall P. J., Taylor D. A., McClelland J. M., Rutkowski S. B., Cousins M. J., Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury. Pain 1999 81 1-2 187 197 2-s2.0-0032930409 10.1016/S0304-3959(99)00023-8 (Pubitemid 29199915)
21. Widerstrom-Noga E., Turk D. C., Outcome measures in chronic pain trials involving people with spinal cord injury. SCI Psychosocial Process 2004 17 258 267
22. Hsieh S. T., Pathology and functional diagnosis of small-fiber painful neuropathy. Acta Neurologica Taiwanica 2010 19 2 82 89 2-s2.0-77955451750
23. St.Onge E. L. S., Miller S. A., Pain associated with diabetic peripheral neuropathy: a review of available treatments. Pharmacology and Therapeutics 2008 33 3 166 179 2-s2.0-42149110903 (Pubitemid 351532384)
24. Fischer T. Z., Waxman S. G., Neuropathic pain in diabetes-evidence for a central mechanism. Nature Reviews Neurology 2010 6 8 462 466 2-s2.0-77956268634 10.1038/nrneurol.2010.90
25. Berger J. V., Knaepen L., Janssen S. P., Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Research Reviews 2011 67 1-2 282 310
26. Roth T., van Seventer R., Murphy T. K., The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials. Current Medical Research and Opinion 2010 26 10 2411 2419 2-s2.0-77956763017 10.1185/03007995.2010.516142
27. Wu H. H., Wilcox G. L., McLoon S. C., Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. Journal of Neuroscience 1994 14 8 4806 4814 2-s2.0-0027991138 (Pubitemid 24237902)
28. Eaton M. J., Karmally S., Martinez M. A., Plunkett J. A., Lopez T., Cejas P. J., Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. Journal of the Peripheral Nervous System 1999 4 3-4 245 257 2-s2.0-0033398487 (Pubitemid 30035584)
29. Eaton M. J., Santiago D. I., Dancausse H. A., Whittemore S. R., Lumbar transplants of immortalized serotonergic neurons alleviate chronic neuropathic pain. Pain 1997 72 1-2 59 69 2-s2.0-0030791867 10.1016/S0304-3959(97)00015-8 (Pubitemid 27321902)
30. Eaton M. J., Plunkett J. A., Martinez M. A., Lopez T., Karmally S., Cejas P., Whittemore S. R., Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplantation 1999 8 1 87 101 2-s2.0-0032867326 (Pubitemid 29408774)
31. Cejas P. J., Martinez M., Karmally S., McKillop M., McKillop J., Plunkett J. A., Oudega M., Eaton M. J., Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain 2000 86 1-2 195 210 2-s2.0-0034193739 10.1016/S0304-3959(00)00245-1 (Pubitemid 30211718)
32. Sagen J., Eaton M. J., Schmidt W. K., Cellular implantation for the treatment of chronic pain. pain: current Understanding, Emerging Therapies, and Novel Approaches to Drug Discovery 2003 New York, NY, USA Marcel Dekker 815 833
33. Eaton M. J., Cell and molecular approaches to the attenuation of pain after spinal cord injury. Journal of Neurotrauma 2006 23 3-4 549 559 2-s2.0-33646573639 10.1089/neu.2006.23.549 (Pubitemid 43726328)
34. Andrews P. W., Damjanov I., Simon D., Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation 1984 50 2 147 162 2-s2.0-0021321996 (Pubitemid 14199076)
35. Andrews P. W., Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Developmental Biology 1984 103 2 285 293 2-s2.0-0021447637
36. Borlongan C. V., Tajima Y., Trojanowski J. Q., Lee V. M. Y., Sanberg P. R., Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Experimental Neurology 1998 149 2 310 321 2-s2.0-0032006347 10.1006/exnr.1997.6730 (Pubitemid 28115069)
37. Newman M. B., Misiuta I., Willing A. E., Zigova T., Karl R. C., Borlongan C. V., Sanberg P. R., Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells and Development 2005 14 1 29 43 2-s2.0-14744274454 (Pubitemid 40328246)
38. Trojanowski J. Q., Kleppner S. R., Hartley R. S., Miyazono M., Fraser N. W., Kesari S., Lee V. M. Y., Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Experimental Neurology 1997 144 1 92 97 2-s2.0-0031106063 10.1006/exnr.1996.6393 (Pubitemid 27149608)
39. Lee V. M. Y., Hartley R. S., Trojanowski J. Q., Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury. Progress in Brain Research 2000 128 299 307 2-s2.0-0034589386 10.1016/S0079-6123(00)28027-8 (Pubitemid 35461246)
40. Hara K., Yasuhara T., Maki M., Matsukawa N., Masuda T., Yu S. J., Ali M., Yu G., Xu L., Kim S. U., Hess D. C., Borlongan C. V., Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Progress in Neurobiology 2008 85 3 318 334 2-s2.0-46449111075 10.1016/j.pneurobio.2008. 04.005
41. Kondziolka D., Wechsler L., Goldstein S., Meltzer C., Thulborn K. R., Gebel J., Jannetta P., DeCesare S., Elder E. M., McGrogan M., Reitman M. A., Bynum L., Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000 55 4 565 569 2-s2.0-0033845975 (Pubitemid 30647258)
42. Yoshioka A., Yudkoff M., Pleasure D., Expression of glutamic acid decarboxylase during human neuronal differentiation: studies using the NTera-2 culture system. Brain Research 1997 767 2 333 339 2-s2.0-0030823417 10.1016/S0006-8993(97)00627-6 (Pubitemid 27435780)
43. Eaton M. J., Wolfe S. Q., Martinez M., Hernandez M., Furst C., Huang J., Frydel B. R., Gómez-Marín O., Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic SCI in the rat. Pain 2007 8 1 33 50 2-s2.0-33845909301 10.1016/j.jpain.2006.05.013 (Pubitemid 46026965)
44. Wolfe S. Q., Garg M., Cumberbatch N. M. A., Furst C., Martinez M., Hernandez M., Reimers R., Berrocal Y., Gómez-Marín O., Eaton M. J., Optimizing the transplant dose of a human neuronal cell line graft to treat SCI pain in the rat. Neuroscience Letters 2007 414 2 121 125 2-s2.0-33847016417 10.1016/j.neulet.2006.10.067 (Pubitemid 46273982)
45. Vaysse L., Sol J. C., Lazorthes Y., Courtade-Saidi M., Eaton M. J., Jozan S., GABAergic pathway in a rat model of chronic neuropathic pain: modulation after intrathecal transplantation of a human neuronal cell line. Neuroscience Research 2011 69 2 111 120 2-s2.0-78650309416 10.1016/j.neures.2010.10.006
46. Eaton M. J., Pearse D. D., McBroom J. S., Berrocal Y. A., The combination of human neuronal serotonergic cell implants and environmental enrichment after contusive SCI improves motor recovery over each individual strategy. Behavioural Brain Research 2008 194 2 236 241 2-s2.0-50549095402 10.1016/j.bbr.2008.07.001
47. Eaton M. J., Widerström-Noga E., Wolfe S. Q., Subarachnoid transplant of a human neuronal serotonergic cell line attenuates chronic allodynia and hyperalgesia without affecting motor dysfunction after severe contusive spinal cord injury. Neurology Research International 2011 2011 24 891605 10.1155/2011/891605
48. Cheung W. M. W., Fu W. Y., Hui W. S., Ip N. Y., Production of human CNS neurons from embryonal carcinoma cells using a cell aggregation method. BioTechniques 1999 26 5 946 954 2-s2.0-0032936126
49. Zhang A.-L., Hao J.-X., Seiger A., Xu X. J., Wiesenfeld-Hallin Z., Grant G., Aldskogius H., Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Research 1994 656 1 187 190 2-s2.0-0027931856 10.1016/0006-8993(94)91383-8 (Pubitemid 24263047)
50. Saporta S., Willing A. E., Colina L. O., Zigova T., Milliken M., Daadi M. M., Sanberg P. R., In vitro and in vivo characterization of hNT neuron neurotransmitter phenotypes. Brain Research Bulletin 2000 53 3 263 268 2-s2.0-0033669223 10.1016/S0361-9230(00)00329-4
51. Woehrling E. K., Hill E. J., Coleman M. D., Development of a neurotoxicity test-system, using human post-mitotic, astrocytic and neuronal cell lines in co-culture. Toxicology in Vitro 2007 21 7 1241 1246 2-s2.0-35649027356 10.1016/j.tiv.2007.04.011 (Pubitemid 350026239)
52. White L. A., Eaton M. J., Castro M. C., Klose K. J., Globus M. Y. T., Shaw G., Whittemore S. R., Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. Journal of Neuroscience I 1994 14 11 6744 6753 2-s2.0-0028073280 (Pubitemid 24333092)
53. Bennett G. J., Xie Y.-K., A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988 33 1 87 107 2-s2.0-0023895875
54. Hama A. T., Sagen J., Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain 1993 52 2 223 231 2-s2.0-0027528437 10.1016/0304-3959(93)90135-C (Pubitemid 23068192)
55. Brewer K. L., Yezierski R. P., Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury. Brain Research 1998 798 1-2 83 92 2-s2.0-0032490593 10.1016/S0006-8993(98)00398-9 (Pubitemid 28342023)
56. Gruner J. A., A monitored contusion model of spinal cord injury in the rat. Journal of Neurotrauma 1992 9 2 123 128 2-s2.0-0026802223
57. Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M., Yaksh T. L., Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 1994 53 1 55 63 2-s2.0-0027933374 10.1016/0165-0270(94) 90144-9 (Pubitemid 24238751)
58. Hargreaves K., Dubner R., Brown F., Flores C., Joris J., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988 32 1 77 88 2-s2.0-0023924046
59. Basso D. M., Beattie M. S., Bresnahan J. C., A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of Neurotrauma 1995 12 1 1 21 2-s2.0-0028919411
60. Popovich P. G., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B. T., Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Experimental Neurology 1999 158 2 351 365 2-s2.0-0032838089 10.1006/exnr.1999.7118 (Pubitemid 29382826)
61. Eaton M. J., Wolfe S. Q., Clinical feasibility for cell therapy utilizing a human neuronal cell line to treat neuropathic pain-like behaviors following SCI in the rat. Journal of Rehabilitation Research & Development 2009 46 1 145 166
62. Spinella M. J., Kitareewan S., Mellado B., Sekula D., Khoo K. S., Dmitrovsky E., Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells. Oncogene 1998 16 26 3471 3480 2-s2.0-0032474851 (Pubitemid 28349690)
63. Dmitrovsky E., Moy D., Miller W. H., Li A., Masui H., Retinoic acid causes a decline in TGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Research 1990 5 3 233 239 2-s2.0-0025237808 (Pubitemid 20088246)
64. Marsala M., Kakinohana O., Yaksh T. L., Tomori Z., Marsala S., Cizkova D., Spinal implantation of hNT neurons and neuronal precursors: graft survival and functional effects in rats with ischemic spastic paraplegia. European Journal of Neuroscience 2004 20 9 2401 2414 2-s2.0-8144224012 10.1111/j.1460-9568.2004.03702.x (Pubitemid 39472402)
65. Nelson P. T., Kondziolka D., Wechsler L., Goldstein S., Gebel J., DeCesare S., Elder E. M., Zhang P. J., Jacobs A., McGrogan M., Lee V. M. Y., Trojanowski J. Q., Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. American Journal of Pathology 2002 160 4 1201 1206 2-s2.0-0036114274 (Pubitemid 34411623)
66. Stilley C. S., Ryan C. M., Kondziolka D., Bender A., de Cesare S., Wechsler L., Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology 2004 63 7 1320 1322 2-s2.0-5344247965 (Pubitemid 39350044)
67. Kondziolka D., Wechsler L., Gebel J., de Cesare S., Elder E., Meltzer C. C., Neuronal transplantation for motor stroke: from the laboratory to the clinic. Physical Medicine and Rehabilitation Clinics of North America 2003 14 1 S153 S160 2-s2.0-0037330562 10.1016/S1047-9651(02)00057-8 (Pubitemid 36259038)
68. Yond V. W., Kim S. U., A new double labelling immunofluorescence technique for the determination of proliferation of human astrocytes in culture. Journal of Neuroscience Methods 1987 21 1 9 16 2-s2.0-0023279810 (Pubitemid 17138750)
69. Brown D. B., Stanfield B. B., The use of bromodeoxyuridine- immunohistochemistry to identify transplanted fetal brain tissue. Journal of Neural Transplantation 1989 1 3-4 135 139 2-s2.0-0024797368 (Pubitemid 20292380)
70. Lariviere W. R., Melzack R., The bee venom test: a new tonic-pain test. Pain 1996 66 2-3 271 277 2-s2.0-0006877378 10.1016/0304-3959(96)03075-8 (Pubitemid 26283997)
71. Sima A. A. F., Sugimoto K., Experimental diabetic neuropathy: an update. Diabetologia 1999 42 7 773 788 2-s2.0-0032789870 10.1007/s001250051227 (Pubitemid 29325066)
72. Field M. J., McCleary S., Hughes J., Singh L., Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999 80 1-2 391 398 2-s2.0-0033030274 10.1016/S0304-3959(98)00239-5 (Pubitemid 29151725)
73. Eaton M. J., Herman J. P., Potter E., Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination effective in cell therapy for pain. Society for Neuroscience 2000 26 1622
74. Eaton M. J., Martinez M. A., Karmally S., A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Research 1999 835 2 334 339 2-s2.0-0033600492 10.1016/S0006-8993(99)01564-4 (Pubitemid 29343798)
75. Galer B. S., Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995 45 12, supplement 9 S17 S25 2-s2.0-0029555639 (Pubitemid 26156628)
76. Wu S. C., Wrobel J. S., Armstrong D. G., Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia. pain Medicine 2007 8 supplement 2 S33 S42 2-s2.0-34548087307 10.1111/j.1526-4637.2007.00350.x (Pubitemid 47288509)
77. Moore R. A., Straube S., Wiffen P. J., Derry S., McQuay H. J., Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009 3 CD007076 2-s2.0-68549125179
78. Yezierski R. P., Liu S., Ruenes G. L., Behavioral and pathological characteristics of a central pain model following spinal injury. Proceedings of the 8th World Congress on pain August 1996 British Columbia, Canada
79. Lindsey A. E., LoVerso R. L., Tovar C. A., Hill C. E., Beattie M. S., Bresnahan J. C., An analysis of changes in sensory thresholds to mild tactile and cold stimuli after experimental spinal cord injury in the rat. Neurorehabilitation and Neural Repair 2000 14 4 287 300 2-s2.0-0034439686 (Pubitemid 32499586)
80. Basso D. M., Beattie M. S., Bresnahan J. C., Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Experimental Neurology 1996 139 2 244 256 2-s2.0-0030157694 10.1006/exnr.1996.0098 (Pubitemid 26228093)
81. Pearse D. D., Bunge M. B., Paralysis research: promoting nerve fiber protection, growth and functional recovery by cyclic AMP and cell transplantation. Discovery Medicine 2004 4 22 199 202
82. Megiorni F., Mora B., Indovina P., Mazzilli M. C., Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method. Neuroscience Letters 2005 373 2 105 109 2-s2.0-9644252803 10.1016/j.neulet.2004. 09.070 (Pubitemid 39572970)
83. Pleasure S. J., Page C., Lee V. M. Y., Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. Journal of Neuroscience 1992 12 5 1802 1815 2-s2.0-0026583471
84. Usvald D., Vodicka P., Hlucilova J., Prochazka R., Motlik J., Kuchorova K., Johe K., Marsala S., Scadeng M., Kakinohana O., Navarro R., Santa M., Hefferan M. P., Yaksh T. L., Marsala M., Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs. Cell Transplantation 2010 19 9 1103 1122 2-s2.0-78649831388 10.3727/096368910X503406
85. Guillemain I., Alonso G., Patey G., Privat A., Chaudieu I., Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. Journal of Comparative Neurology 2000 422 3 380 395 2-s2.0-0034601131 (Pubitemid 30387669)
86. Podrygajlo G., Tegenge M. A., Gierse A., Paquet-Durand F., Tan S., Bicker G., Stern M., Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture. Cell and Tissue Research 2009 336 3 439 452 2-s2.0-67349217830 10.1007/s00441-009-0783-0
87. Alenina N., Bashammakh S., Bader M., Specification and differentiation of serotonergic neurons. Stem Cell Reviews 2006 2 1 5 10 2-s2.0-33746882090 10.1385/SCR:2:1:5 (Pubitemid 44195972)
88. Berninger B., Guillemot F., Götz M., Directing neurotransmitter identity of neurones derived from expanded adult neural stem cells. European Journal of Neuroscience 2007 25 9 2581 2590 2-s2.0-34250004608 10.1111/j.1460-9568.2007.05509.x (Pubitemid 46888827)
89. Wang B., Zou X., Zhang H., Duan D., Ju L., Jiang X., Sun X., Zhao C., Zhao H., Guo J., Xu C., Gao E., Xu Q., Establishment of an immortalized GABAergic neuronal progenitor cell line from embryonic ventral mesencephalon in the rat. Brain Research 2008 1210 63 75 2-s2.0-43049156398 10.1016/j.brainres. 2008.02.062
90. Gokhan S., Song Q., Mehler M. F., Generation and regulation of developing immortalized neural cell lines. Methods 1998 16 3 345 358 2-s2.0-0032453196 10.1006/meth.1998.0689 (Pubitemid 29112282)
91. Eaton M. J., Staley J. K., Globus M. Y. Y., Whittemore S. R., Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Developmental Biology 1995 170 1 169 182 2-s2.0-0029119322 10.1006/dbio.1995. 1205
92. Eaton M. J., Whittemore S. R., ACTH activation of adenylate cyclase in raphe neurons: multiple regulatory pathways control serotonergic neuronal differentiation. Journal of Neurobiology 1995 28 4 465 481 2-s2.0-0028805933 10.1002/neu.480280407
93. Rudge J. S., Eaton M. J., Mather P., Lindsay R. M., Whittemore S. R., CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro. Molecular and Cellular Neurosciences 1996 7 3 204 221 2-s2.0-0029893948 10.1006/mcne.1996.0016 (Pubitemid 26171284)
94. Eaton M. J., Frydel B., Lopez T., Generation and initial characterization of conditionally immortalized chromaffin cells. Journal of Cellular Biochemistry 2000 79 1 38 57
95. Hains B. C., Johnson K. M., McAdoo D. J., Engraftment of immortalized serotonergic neurons enhances locomotor function and attenuates pain-like behavior following spinal hemisection injury in the rat. Experimental Neurology 2001 171 2 361 378 (Pubitemid 32955298)
96. Hains B. C., Johnson K. M., Eaton M. J., Willis W. D., Hulsebosch C. E., Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience 2003 116 4 1097 1110 2-s2.0-0037470570 10.1016/S0306-4522(02)00729-7 (Pubitemid 36262968)
97. Duplan H., Li R. Y., Vue C., Zhou H., Emorine L., Herman J. P., Tafani M., Lazorthes Y., Eaton M. J., Grafts of immortalized chromaffin cells bio-engineered to improve met-enkephalin release also reduce formalin-evoked c-fos expression in rat spinal cord. Neuroscience Letters 2004 370 1 1 6 2-s2.0-5644251713 10.1016/j.neulet.2004.07.017 (Pubitemid 39369846)
98. Eaton M. J., Vaysse L., Herman J. P., Creation of immortalized chromaffin cell lines for clinical applications. IRPCA Advances and Research Updates 2007 9 1 13 26
99. Sagen J., Cellular therapies for spinal cord injury: what will the FDA need to approve moving from the laboratory to the human? Journal of Rehabilitation Research and Development 2003 40 supplement 1 71 79 2-s2.0-0043233331 (Pubitemid 36988682)
100. Ditto A. J., Shah P. N., Yun Y. H., Non-viral gene delivery using nanoparticles. Expert Opinion on Drug Delivery 2010 6 11 1149 1160
101. Hartley R. S., Margulis M., Fishman P. S., Functional synapses are formed betweeen human NTera2 (NT2N, hNT) neurons grown on astrocytes. The Journal of Comparative Neurology 1999 407 1 1 10 (Pubitemid 29161989)
102. Soprano D. R., Teets B. W., Soprano K. J., Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitamins and Hormones 2007 75 69 95
103. Cheung W. M., Chu A. H., Ip N. Y., Indentification of candidate genes induced by retinoic acid in embryonal carcinoma cells. Journal of Neurochemistry 1997 68 5 1882 1888 (Pubitemid 27176123)
104. Baselga J., Maerz W. J., Moy D., Miller W. H., Castro L., Reuter V. E., Yao T. J., Masui H., Dmitrovsky E., Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell. Oncogene 1993 8 12 3257 3263 2-s2.0-0027432898 (Pubitemid 23342622)
105. Baldassarre G., Boccia A., Bruni P., Sandomenico C., Barone M. V., Pepe S., Angrisano T., Belletti B., Motti M. L., Fusco A., Viglietto G., Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth and Differentiation 2000 11 10 517 526 2-s2.0-0033764652
106. Curtin J. C., Dragnev K. H., Sekula D., Christie A. J., Dmitrovsky E., Spinella M. J., Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function. Oncogene 2001 20 20 2559 2569 2-s2.0-0035799528 10.1038/sj.onc.1204370 (Pubitemid 32531353)
107. Fang H., Chartier J., Sodja C., Desbois A., Ribecco-Lutkiewicz M., Walker P. R., Sikorska M., Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons. Journal of Biological Chemistry 2003 278 29 26401 26409 2-s2.0-0038374392 10.1074/jbc.M211539200 (Pubitemid 36876779)
108. Miyazono M., Lee V. M. Y., Trojanowski J. Q., Proliferation, cell death, and neuronal differentiation in transplanted human embryonal carcinoma (NTera2) cells depend on the graft site in nude and severe combined immunodeficient mice. Laboratory Investigation 1995 73 2 273 283 2-s2.0-0029147116
109. Lazorthes Y., Sagen J., Sallerin B., Tkaczuk J., Duplan H., Sol J. C., Tafani M., Bès J. C., Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain 2000 87 1 19 32 2-s2.0-0034237197 10.1016/S0304-3959(00)00263-3 (Pubitemid 30345658)
110. Bakay R. A. E., Boyer K. L., Freed C. R., Ansari A. A., Immunological responses to injury and grafting in the central nervous system of nonhuman primates. Cell Transplantation 1998 7 2 109 120 2-s2.0-0031953762 10.1016/S0963-6897(97)00165-6 (Pubitemid 28182747)
111. Barrett A. J., Rezvani K., Solomon S., Dickinson A. M., Wang X. N., Stark G., Cullup H., Jarvis M., Middleton P. G., Chao N., New developments in allotransplant immunology. Hematology 2003 350 371 2-s2.0-4444252147
112. Hori J., Ng T. F., Shatos M., Klassen H., Streilein J. W., Young M. J., Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003 21 4 405 416 2-s2.0-0037820641 (Pubitemid 36798086)
113. Stubley L. A., Martinez M. A., Karmally S., Lopez T., Cejas P., Eaton M. J., Only early intervention with gamma-aminobutyric acid cell therapy is able to reverse neuropathic pain after partial nerve injury. Journal of Neurotrauma 2001 18 4 471 477 2-s2.0-0035055907 (Pubitemid 32336552)
114. Schott G. D., Delayed onset and resolution of pain. Some observations and implications. Brain 2001 124, part 6 1067 1076 2-s2.0-0034989946 (Pubitemid 32510375)
115. Sharma U., Griesing T., Emir B., Young J. P., Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. American Journal of Therapeutics 2010 17 6 577 585 2-s2.0-78149359581 10.1097/MJT.0b013e3181d5e4f3
116. Hentall I. D., Sagen J., The alleviation of pain by cell transplantation. Progress in Brain Research 2000 127 535 550 2-s2.0-0034589759 10.1016/S0079-6123(00)27027-1 (Pubitemid 35461276)
117. Bhattacharya N., Chhetri M. K., Mukherjee K. L., Human fetal adrenal transplant: a possible role in relieving intractable pain in advanced rheumatoid arthritis. Clinical & Experimental Obstetrics & Gynecology 2002 29 3 197 206 (Pubitemid 36004700)
118. Hains B. C., Chastain K. M., Everhart A. W., McAdoo D. J., Hulsebosch C. E., Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury. Experimental Neurology 2000 164 2 426 437 2-s2.0-0034528448 10.1006/exnr.2000.7439 (Pubitemid 32010740)
119. Eaton M. J., Martinez M., Karmally S., Lopez T., Sagen J., Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain. Cell Transplantation 2000 9 5 637 656 2-s2.0-0034535657 (Pubitemid 32002570)
120. Eaton M. J., Development of human cell therapy for functional recovery following SCI. The Journal of Spinal Cord Medicine 2004 27 155
121. Kim Y. M., Kwak K. H., Lim J. O., Baek W. Y., Reduction of allodynia by intrathecal transplantation of microencapsulated porcine chromaffin cells. Artificial Organs 2009 33 3 240 249 2-s2.0-61349166416 10.1111/j.1525-1594.2009. 00714.x
122. Ning G. Z., Yu T. Q., Feng S. Q., Zhou X. H., Ban D. X., Liu Y., Jiao X. X., Epidemiology of traumatic spinal cord injury in Tianjin, China. Spinal Cord 2010 49 3 386 390 2-s2.0-77957280594 10.1038/sc.2010.130
123. Modirian E., Pirouzi P., Soroush M., Karbalaei-Esmaeili S., Shojaei H., Zamani H., Chronic pain after spinal cord injury: results of a long-term study. pain Medicine 2010 11 7 1037 1043 2-s2.0-77955139461 10.1111/j.1526-4637.2010. 00865.x
124. Dalyan M., Cardenas D. D., Gerard B., Upper extremity pain after spinal cord injury. Spinal Cord 1999 37 3 191 195 2-s2.0-0033027381 (Pubitemid 29149995)
125. Bennett G. J., Fields H. L., Liebeskind J. C., Chronic pain due to peripheral nerve damage: an overview. Pharmacological Approaches to the Treatment of Chronic pain: New Concepts and Critical Issues 1994 Seattle, Wash, USA IASP Press 51 60
126. Yezierski R. P., Liu S., Ruenes G. L., Kajander K. J., Brewer K. L., Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain 1998 75 1 141 155 2-s2.0-0031780474 10.1016/S0304-3959(97)00216-9 (Pubitemid 28254865)
127. Yu C. G., Fairbanks C. A., Wilcox G. L., Yezierski R. P., Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats. Pain 2003 4 3 129 140 2-s2.0-0242516018 10.1054/jpai.2003.11 (Pubitemid 36523432)
128. Hains B. C., Bennett A. D., Eaton M. J., Intralesion transplantation of serotonin- and BDNF-secreting cells promotes recovery of locomotor function after spinal hemisection injury. Society for Neuroscience 2001 27 2039
129. Berrocal Y., Pearse D. D., Singh A., Andrade C. M., McBroom J. S., Puentes R., Eaton M. J., Social and environmental enrichment improves sensory and motor recovery after severe contusive spinal cord injury in the rat. Journal of Neurotrauma 2007 24 11 1761 1772 2-s2.0-39449123614 10.1089/neu.2007.0327 (Pubitemid 351267790)
130. Novak C. B., Katz J., Neuropathic pain in patients with upper-extremity nerve injury. Physiotherapy Canada 2010 62 3 190 201 2-s2.0-77958001231 10.3138/physio.62.3.190
131. Chong M. S., Hester J., Diabetic painful neuropathy: current and future treatment options. Drugs 2007 67 4 569 585 2-s2.0-33947310739 10.2165/00003495-200767040-00006 (Pubitemid 46440313)
132. Hwang J. H., Yaksh T. L., The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain 1997 70 1 15 22 2-s2.0-0030966704 10.1016/S0304-3959(96)03249-6 (Pubitemid 27128293)
133. Wolfe S. Q., Holohean A. M., Martinez M., Intrathecal transplant of the human neuronal GABA/glycinergic hNT2.17 cell line for the alleviation of neuropathic pain in the streptozotocin (STZ) model of diabetic neuropathy. Neurosurgery 2008 62 6 1427
134. Obrosova I. G., Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009 6 4 638 647 2-s2.0-70349303776 10.1016/j.nurt.2009.07.004
135. Calcutt N. A., Potential mechanisms of neuropathic pain in diabetes. International Review of Neurobiology 2002 50 205 228 2-s2.0-0036369155
136. Remuzzi A., Cornolti R., Bianchi R., Figliuzzi M., Porretta-Serapiglia C., Oggioni N., Carozzi V., Crippa L., Avezza F., Fiordaliso F., Salio M., Lauria G., Lombardi R., Cavaletti G., Regression of diabetic complications by islet transplantation in the rat. Diabetologia 2009 52 12 2653 2661 2-s2.0-70949103630 10.1007/s00125-009-1537-y
137. Speight J., Reaney M. D., Woodcock A. J., Smith R. M., Shaw J. A. M., Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review. Diabetic Medicine 2010 27 7 812 822 2-s2.0-77954304378 10.1111/j.1464-5491.2010.03029.x
138. Gibbons C. H., Freeman R., Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Annals of Neurology 2010 67 4 534 541 2-s2.0-77951730299 10.1002/ana.21952
139. Mittal M., Pasnoor M., Mummaneni R. B., Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. International Journal of Neuroscience 2011 121 9 521 527
140. Guastella V., Mick G., Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy. Diabetes and Metabolism 2009 35 1 12 19 2-s2.0-60349130560 10.1016/j.diabet. 2008.09.003
141. Heeg S., Doebele M., von Werder A., Opitz O. G., In vitro transformation models: modeling human cancer. Cell Cycle 2006 5 6 630 634 2-s2.0-33645303498
142. Wolfe S. Q., Cumberbatch N., Menendez I., Martinez M., Eaton M., Intrathecal transplantation of a human neuronal cell line for the treatment of neuropathic pain in a spinal cord injury model. Clinical neurosurgery 2007 54 220 225 2-s2.0-47249092446
143. Brumley M. R., Hentall I. D., Pinzon A., Kadam B. H., Blythe A., Sanchez F. J., Taberner A. M., Noga B. R., Serotonin concentrations in the lumbosacral spinal cord of the adult rat following microinjection or dorsal surface application. Journal of Neurophysiology 2007 98 3 1440 1450 2-s2.0-34548806413 10.1152/jn.00309.2007 (Pubitemid 47435894)
144. Majczyński H., Maleszak K., Cabaj A., Sławińska U., Serotonin-related enhancement of recovery of hind limb motor functions in spinal rats after grafting of embryonic raphe nuclei. Journal of Neurotrauma 2005 22 5 590 604 2-s2.0-18844408208 10.1089/neu.2005.22.590 (Pubitemid 40726985)
145. Feraboli-Lohnherr D., Orsal D., Yakovleff A., Giménez Y Ribotta M., Privat A., Recovery of locomotor activity in the adult chronic spinal rat after sublesional transplantation of embryonic nervous cells: specific role of serotonergic neurons. Experimental Brain Research 1997 113 3 443 454 2-s2.0-0030889982 10.1007/PL00005597 (Pubitemid 27140268)
146. Hains B. C., Yucra J. A., Eaton M. J., Hulsebosch C. E., Intralesion transplantation of serotonergic precursors enhances locomotor recovery but has no effect on development of chronic central pain following hemisection injury in rats. Neuroscience Letters 2002 324 3 222 226 2-s2.0-0037166072 10.1016/S0304-3940(02)00194-5 (Pubitemid 34493874)
147. Cardenas D. D., Turner J. A., Warms C. A., Inter-rater reliability of a pain classification system for spinal cord injury. Journal of Spinal Cord Medicine 2001 24 S20
148. Hains B. C., Fullwood S. D., Eaton M. J., Hulsebosch C. E., Subdural engraftment of serotonergic neurons following spinal hemisection restores spinal serotonin, downregulates serotonin transporter, and increases BDNF tissue content in rat. Brain Research 2001 913 1 35 46 2-s2.0-0035860599 10.1016/S0006-8993(01)02749-4 (Pubitemid 32786929)
149. Todd A. J., McKenzie J., GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience 1989 31 3 799 806 2-s2.0-0024835205 10.1016/0306-4522(89)90442-9 (Pubitemid 20032966)
150. Desarmenien M., Feltz P., Occhipinti G., Coexistence of GABA(A) and GABA(B) receptors on Ad and C primary afferents. British Journal of Pharmacology 1984 81 2 327 333 2-s2.0-0021288994 (Pubitemid 14149410)
151. Malcangio M., Bowery N. G., GABA and its receptors in the spinal cord. Trends in Pharmacological Sciences 1996 17 12 457 462 2-s2.0-0030459624 10.1016/S0165-6147(96)01013-9 (Pubitemid 27028478)
152. Sieghart W., GABA-A receptors: ligand-gated Cl- channels modulated by multiple drug-binding sites. Trends in Pharmacological Sciences 1992 72 169 179
153. Hulsebosch C. E., Christensen M. D., Peng Y. B., Central sensitization of wide dynamic range neurons in chronic central pain after spinal cord hemisection. American pain Society 1995 95812
154. Yezierski R. P., Santana M., Park S. H., Madsen P. W., Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat. Journal of Neurotrauma 1993 10 4 445 456 2-s2.0-0027731852 (Pubitemid 24024923)
155. Stiller C. O., Cui J. G., O'Connor W. T., GABA-ergic mechanisms may be involved in the spinal cord stimulation induced reversion of allodynia: animal studies with microdialysis. American pain Society 1995 95 801
156. Kingery W. S., Fields R. D., Kocsis J. D., Diminished dorsal root GABA sensitivity following chronic peripheral nerve injury. Experimental Neurology 1988 100 3 478 490 2-s2.0-0023906505
157. Meisner J. G., Marsh A. D., Marsh D. R., Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. Journal of Neurotrauma 2010 27 4 729 737 2-s2.0-77951294191 10.1089/neu.2009.1166
158. Kjaer M., Nielsen H., The analgesic effect of the GABA-agonist THIP in patients with chronic pain of malignant origin. A phase-1-2 study. British Journal of Clinical Pharmacology 1983 16 5 477 485 2-s2.0-0021054019 (Pubitemid 14239695)
159. Gwak Y. S., Tan H. Y., Nam T. S., Paik K. S., Hulsebosch C. E., Leem J. W., Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. Journal of Neurotrauma 2006 23 7 1111 1124 2-s2.0-33746679191 10.1089/neu.2006.23.1111 (Pubitemid 44162716)
160. Enna S. J., McCarson K. E., The role of GABA in the mediation and perception of pain. Advances in Pharmacology 2006 54 1 27 2-s2.0-33846158169 10.1016/S1054-3589(06)54001-3
161. Ibuki T., Hama A. T., Wang X. T., Pappas G. D., Sagen J., Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 1996 76 3 845 858 2-s2.0-0030580562 10.1016/S0306-4522(96)00341-7 (Pubitemid 27013423)
162. Yamamoto T., Yaksh T. L., Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801. Pain 1993 54 1 79 84 2-s2.0-0027300596 10.1016/0304-3959(93)90102-U (Pubitemid 23200574)
163. Kim S. H., Chung J. M., An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992 50 3 355 363 2-s2.0-0026727999 10.1016/0304-3959(92)90041-9
164. Linderoth B., Stiller C. O., O'Connor W. T., An animal model for the study of brain transmitter release in response to spinal cord stimulation in the awake, freely moving rat: preliminary results from the periaqueductal grey matter. Acta Neurochirurgica Supplementum 1993 58 156 160
165. Thomas D. A., Navarrete I. M., Graham B. A., McGowan M. K., Hammond D. L., Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats. Brain Research 1996 718 1-2 129 137 2-s2.0-0029950247 10.1016/0006-8993(96)00100-X (Pubitemid 26168736)
166. Xu X.-J., Hao J.-X., Aldskogius H., Seiger A., Wiesenfeld-Hallin Z., Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 1992 48 2 279 290 2-s2.0-0026501374 10.1016/0304-3959(92)90070-R
167. Moore K. A., Kohno T., Karchewski L. A., Scholz J., Baba H., Woolf C. J., Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. Journal of Neuroscience 2002 22 15 6724 6731 2-s2.0-0036703985 (Pubitemid 35386428)
168. Polgár E., Todd A. J., Tactile allodynia can occur in the spared nerve injury model in the rat without selective loss of GABA or GABAA receptors from synapses in laminae I-II of the ipsilateral spinal dorsal horn. Neuroscience 2008 156 1 193 202 2-s2.0-51249118483 10.1016/j.neuroscience.2008. 07.009
169. Polgár E., Hughes D. I., Riddell J. S., Maxwell D. J., Puskár Z., Todd A. J., Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain 2003 104 1-2 229 239 2-s2.0-0037485919 10.1016/S0304-3959(03)00011-3 (Pubitemid 36835892)
170. Engle M. P., Gassman M., Sykes K. T., Bettler B., Hammond D. L., Spinal nerve ligation does not alter the expression or function of GABAB receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience 2006 138 4 1277 1287 2-s2.0-33644843470 10.1016/j.neuroscience.2005.11.064 (Pubitemid 43363544)
171. Eaton M. J., Plunkett J. A., Martinez M. A., Changes in GAD and GABA immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic neurons. Journal of Chemical Neuroanatomy 1998 16 1 57 72 (Pubitemid 29049099)
172. Feldblum S., Dumoulin A., Anoal M., Comparative distribution of GAD65 and GAD67 mRNAs and proteins in the rat spinal cord supports a differential regulation of these two glutamate decarboxylases in vivo. Journal of Neuroscience Research 1995 42 6 742 757
173. Rimvall K., Martin D. L., The level of GAD67 protein is highly sensitive to small increases in intraneuronal gamma-aminobutyric acid levels. Journal of Neurochemistry 1994 62 4 1375 1381
174. Rimvall K., Sheikh S. N., Martin D. L., Effects of increased gamma-aminobutyric acid levels on GAD67 protein and mRNA levels in rat cerebral cortx. Journal of Neurochemistry 1993 60 2 714 720 (Pubitemid 23030972)
175. Towers S., Bowery N., Bettler B., GBR mRNAs and GABA-B binding in the spinal cord and dorsal root ganglia during chronic pain. Society for Neuroscience. In press
176. Greene D. A., Stevens M. J., Feldman E. L., Diabetic neuropathy: scope of the syndrome. American Journal of Medicine 1999 107 2 2-s2.0-0032841226
177. Partanen J., Niskanen L., Lehtinen J., Mervaala E., Siitonen O., Uusitupa M., Natural history of peripheral neuropathy in patients with non-insulin- dependent diabetes mellitus. New England Journal of Medicine 1995 333 2 89 94 2-s2.0-0029038374 10.1056/NEJM199507133330203
178. Sorensen L., Molyneaux L., Yue D. K., Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic control. Diabetes Research and Clinical Practice 2002 57 1 45 51 (Pubitemid 34463019)
179. Galer B. S., Gianas A., Jensen M. P., Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Research and Clinical Practice 2000 47 2 123 128 2-s2.0-0033988613 10.1016/S0168-8227(99) 00112-6 (Pubitemid 30009719)
180. Otto M., Bak S., Bach F. W., Jensen T. S., Sindrup S. H., Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 2003 101 1-2 187 192 2-s2.0-0037223673 10.1016/S0304-3959(02)00313-5 (Pubitemid 36044666)
181. Corbett C. F., Practical management of patients with painful diabetic neuropathy. Diabetes Educator 2005 31 4 523 540 2-s2.0-23944468054 10.1177/0145721705278800 (Pubitemid 41187202)
182. Hasegawa T., Kosaki A., Shimizu K., Matsubara H., Mori Y., Masaki H., Toyoda N., Inoue-Shibata M., Nishikawa M., Iwasaka T., Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Experimental Neurology 2006 199 2 274 280 2-s2.0-33745275141 10.1016/j.expneurol.2005.11.001 (Pubitemid 43928955)
183. Besson J. M., Chaouch A., Akil H., Lewis J. W., Descending serotonergic systems. Neurotransmitters and pain Control 1987 New York, NY, USA Karger 64 100
184. Akil H., Liebeskind J. C., Monoaminergic mechanisms of stimulation produced analgesia. Brain Research 1975 94 2 279 296 2-s2.0-0016833442 10.1016/0006-8993(75)90062-1
185. Jones S. L., Descending noradrenergic influences on pain. Progress in Brain Research 1991 88 381 394 2-s2.0-0025884066
186. Bowker R. M., Westlund K. N., Coulter J. D., Origins of serotonergic projections to the lumbar spinal cord in the monkey using a combined retrograde transport and immunocytochemical technique. Brain Research Bulletin 1982 9 1-6 271 278 2-s2.0-0020468138 (Pubitemid 13225273)
187. Marlier L., Sandillon F., Poulat P., Serotonergic innervation of the dorsal rat spinal cord: light and electron microscopic immunocytochemistry study. Journal of Neurocytology 1991 20 4 310 322
188. Skagerberg G., Bjorklund A., Response properties of upper cervical spinothalamic neurons in cats: a possible explanation for the unusual sensory symptoms associated with upper cervical lesions in humans. Neuroscience 1985 15 445 480
189. Fields H. L., Basbaum A. I., Wall P. D., Melzack R., Endogenous pain control mechanisms. Textbook of Pain 1984 London, UK Churchill Livingston 142 152
190. Besson J. M., Chaouch A., Peripheral and spinal mechanisms of nociception. Physiological Reviews 1987 67 1 67 186 2-s2.0-0023093009 (Pubitemid 17056803)
191. Sanchez A., Niedbala B., Feria M., Modulation of neuropathic pain in rats by intrathecally injected serotonergic agonists. NeuroReport 1995 6 18 2585 2588 2-s2.0-0029598503 (Pubitemid 26032262)
192. Solomon R. E., Gebhart G. F., Mechanisms of effects of intrathecal serotonin on nociception and blood pressure in rats. Journal of Pharmacology and Experimental Therapeutics 1988 245 3 905 912 2-s2.0-0023925103
193. Yaksh T. L., Wilson P. R., Spinal serotonin terminal system mediates antinociception. Journal of Pharmacology and Experimental Therapeutics 1979 208 3 446 453 2-s2.0-0018352151 (Pubitemid 9199954)
194. Willcockson W. S., Chung J. M., Hori Y., Effects of iontophoretically released amino acids and amines on primate spinothalamic tract cells. Journal of Neuroscience 1984 4 3 732 740 2-s2.0-0021246053 (Pubitemid 14127183)
195. Shapiro S., Neurotransmission by neurons that use serotonin, noradrenaline, glutamate, glycine, and gamma-aminobutyric acid in the normal and injured spinal cord. Neurosurgery 1997 40 1 168 176
196. Zhang B., Goldberger M. E., Murray M., Proliferation of SP- and 5HT-containing terminals in lamina II of rat spinal cord following dorsal rhizotomy: quantitative EM-immunocytochemial studies. Experimental Neurology 1993 123 1 51 63 2-s2.0-0027496604 10.1006/exnr.1993.1139 (Pubitemid 23294573)
197. Hains B. C., Everhart A. W., Fullwood S. D., Hulsebosch C. E., Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Experimental Neurology 2002 175 2 347 362 2-s2.0-0036282045 10.1006/exnr.2002.7892 (Pubitemid 34634289)
198. Hains B. C., Willis W. D., Hulsebosch C. E., Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat. Experimental Brain Research 2003 149 2 174 186 2-s2.0-0037337198 (Pubitemid 36315367)
199. Bruce J. C., Oatway M. A., Weaver L. C., Chronic pain after clip-compression injury of the rat spinal cord. Experimental Neurology 2002 178 1 33 48 2-s2.0-0036444138 10.1006/exnr.2002.8026 (Pubitemid 35425607)
200. Faden A. I., Gannon A., Basbaum A. I., Use of serotonin immunocytochemistry as a marker of injury severity after experimental spinal trauma in rats. Brain Research 1988 450 1-2 94 100 2-s2.0-0023878114
201. Fong A. J., Cai L. L., Otoshi C. K., Reinkensmeyer D. J., Burdick J. W., Roy R. R., Edgerton V. R., Spinal cord-transected mice learn to step in response to quipazine treatment and robotic training. Journal of Neuroscience 2005 25 50 11738 11747 2-s2.0-30744456837 10.1523/JNEUROSCI.1523-05.2005 (Pubitemid 43098466)
202. Berger A. J., Bayliss D. A., Viana F., Modulation of neonatal rat hypoglossal motoneuron excitability by serotonin. Neuroscience Letters 1992 143 1-2 164 168
203. Rossignol S., Lund J. P., Drew T., Cohen A. H., Rossignol S., Grillner S., The role of sensory inputs in regulating patterns of rhythmical movements in higher vertebrates. A comparison between locomotion, respiration and mastication. Neural Control of Rhythmic Movements in Vertebrates 1988 New York, NY, USA Wiley 201 283
204. Slawinska U., Majczynski H., Djavadian R., Recovery of hindlimb motor functions after spinal cord transection is enhanced by grafts of embryonic raphe nuclei. Experimental Brain Research 2000 132 1 27 38 (Pubitemid 30218959)
205. White S. R., Neuman R. S., Facilitation of spinal motoneuron excitability by 5-hydroxytryptamine and noradrenaline. Brain Research 1980 188 1 119 127 2-s2.0-0018907986 10.1016/0006-8993(80)90561-2 (Pubitemid 10157098)
206. Stamford J. A., Descending control of pain. British Journal of Anaesthesia 1995 75 2 217 227 2-s2.0-0029085649
207. Borlongan C. V., McWhirter C., Fultz-Carver C., The case for an ethics research consortium for emerging technologies: public perception of stem cell research and development. Technology & Innovation 2010 12 1 21 28 10.3727/194982410X12741230805263